Cargando…
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo
Neurodegenerative diseases are increasingly prevalent in the aging population, yet no disease‐modifying treatments are currently available. Increasing the expression of the cold‐shock protein RBM3 through therapeutic hypothermia is remarkably neuroprotective. However, systemic cooling poses a health...
Autores principales: | Preußner, Marco, Smith, Heather L, Hughes, Daniel, Zhang, Min, Emmerichs, Ann‐Kathrin, Scalzitti, Silvia, Peretti, Diego, Swinden, Dean, Neumann, Alexander, Haltenhof, Tom, Mallucci, Giovanna R, Heyd, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165353/ https://www.ncbi.nlm.nih.gov/pubmed/36946385 http://dx.doi.org/10.15252/emmm.202217157 |
Ejemplares similares
-
TrkB signaling regulates the cold-shock protein RBM3-mediated neuroprotection
por: Peretti, Diego, et al.
Publicado: (2021) -
RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration
por: Peretti, Diego, et al.
Publicado: (2015) -
HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion
por: Lin, Julie Qiaojin, et al.
Publicado: (2023) -
Alternative Splicing of Cdh23 Exon 68 Is Regulated by RBM24, RBM38, and PTBP1
por: Li, Nana, et al.
Publicado: (2020) -
Characterization of TTN Novex Splicing Variants across Species and the Role of RBM20 in Novex-Specific Exon Splicing
por: Chen, Zhilong, et al.
Publicado: (2018)